Respiratory Function and Oxygenation in Smokers and Non-smokers
ConditionSmoking, Tobacco
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorKirsehir Ahi Evran Universitesi
About this trial
This study aimed to compare respiratory function, exercise capacity, and intercostal muscle oxygenation in healthy smokers and non-smokers.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
According to the World Health Organization and ICD smoking addiction criteria, consuming at least one cigarette every day for the last year
Volunteering to participate in research
Able to walk and cooperate
Disqualifiers
Having any cardiopulmonary disease
Having a musculoskeletal problem that could affect the tests
Failure to comply with tests
According to the World Health Organization and ICD smoking addiction criteria, having never smoked or not having smoked in the last year
Trial population
Individuals with smokers and non-smokers will be included in the study.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
42 Participants
are grouped into 2 trial groupsGroup A: Smokers
Group B: Non-smokers
Trial outcomes
Primary outcomes
1
Forced vital capacity
Forced vital capacity (FVC) will be assessed using spirometry.
Time frame
1st day2
Forced expiratory volume in one second
Forced expiratory volume in one second (FEV1) will be assessed using spirometry
Time frame
1st day3
Forced expiratory volume in one second/forced vital capacity ratio
Forced expiratory volume in one second/forced vital capacity ratio will be assessed using spirometry.
Time frame
1st day4
Peak expiratory flow
Peak expiratory flow (PEF) will be assessed using spirometry.
Time frame
1st daySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov